Acupuncture for Generalized Anxiety Disorder
Efficacy of Different Electroacupuncture Parameters for Generalized Anxiety Disorder: A Randomized Controlled Trial
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Xiaoting Wu, Doctor
- Número de teléfono: +8618196671636
- Correo electrónico: xiaotwu@163.com
Ubicaciones de estudio
-
-
Zhejiang
-
Hangzhou, Zhejiang, Porcelana
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Only those who meet the following four criteria simultaneously can be included in this study:
- Meet the diagnostic criteria for GAD;
- Between 18 and 60 years old;
- Conscious and able to communicate normally;
- Have good compliance, be willing to cooperate with the study, and sign the informed consent form.
Exclusion Criteria:
Exclude patients meeting any of the following criteria:
- Organic mental disorder, schizophrenia, bipolar disorder, mania/other psychoses, alcohol/drug addiction, current drug use disorder/lifetime drug abuse, post-stroke/postpartum anxiety;
- History of suicidal behavior or severe suicidal tendency;
- Pregnancy or breastfeeding;
- Mental retardation, unable to cooperate;
- Electroacupuncture contraindications: bleeding tendency, coagulation dysfunction, internal metal implants;
- Participation in other clinical trials within 1 month.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Comparador falso: sham electroacupuncture group (SEA group)
In the SEA group, shallow punctures were made at the points 1 cm outward/radially from bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6), and Sishencong (EX-HN1) respectively, and then the power was cut off after connecting the electro - acupuncture device.Each treatment lasts 30 minutes, with 3 treatments per week for 4 consecutive weeks, totaling 12 treatments.
|
After connecting the electro - acupuncture device, the power was cut off for 30 minutes each time.Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
|
|
Experimental: 2Hz continuous wave electroacupuncture group (2Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 2Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Experimental: 100Hz continuous wave electroacupuncture group (100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Experimental: 2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz/100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
the score of Hamilton anxiety rating scale, HAMA
Periodo de tiempo: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 14 items.
Trained physicians or assessors conduct a semi-structured interview to rate the subject's recent anxiety symptoms.
The items cover two major dimensions: psychic anxiety (e.g., tension, fear) and somatic anxiety (e.g., muscle tension, cardiovascular symptoms).A higher score indicates more severe symptoms, with 7 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
the score of Zung self-rating anxiety scale, SAS
Periodo de tiempo: week 0, week 4, week 8 and week 16 after enrollment
|
This rating scale contains 20 items, and subjects complete the self-assessment independently without external interference.
The standard score ranges from 25 to 100.
A higher SAS score indicates more severe symptoms, with 53 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Pittsburgh sleep quality index, PSQI
Periodo de tiempo: week 0, week 4, week 8 and week 16 after enrollment
|
PSQI is commonly used to assess the sleep quality of participants over the past month.
The total score ranges from 0 to 21.
A higher PSQI score indicates poorer sleep quality, with a cut-off value of 7.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Short form-12 health survey, SF-12
Periodo de tiempo: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 12 items, which is used to evaluate the recent health status of subjects, covering dimensions including physical function, pain, vitality, and social function.
A higher score indicates better health status, and a standard score below 50 indicates that the health status is below the average level.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Periodo de tiempo: From enrollment to the end of treatment at 4 weeks
|
Details of all adverse events will be recorded on the Case Report Form (CRF).
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 after the completion of the trial.
|
From enrollment to the end of treatment at 4 weeks
|
|
acupuncture compliance rate
Periodo de tiempo: 4 weeks after treatment
|
At the end of the acupuncture intervention (end of week 4), compliance will be evaluated with the formula: Compliance Rate = (actual treatment times/total treatment times) *100%.
|
4 weeks after treatment
|
|
the level of Heart Rate Variability
Periodo de tiempo: week 0 and week 6 after enrollment
|
After obtaining the consent of the subjects, the level of Heart Rate Variability data will be collected before and after the intervention to further explore the anti - anxiety mechanism of electroacupuncture.
|
week 0 and week 6 after enrollment
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- MR-33-25-070485
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .